PrioNet funds unique research collaboration

PrioNet Canada is funding a unique collaboration of academic and industry researchers to develop vaccines for prion disease that may also generate effective therapies for common cancers. Funded through PrioNet's Bootstrap program, the research will explore certain regions within prion proteins (epitopes) that may be ideal targets for developing vaccines. The project is led by PrioNet scientific director Dr Neil Cashman in conjunction with Dr Dawn Waterhouse (BC Cancer Agency) and Dr Yuzhuo Wang (BC Cancer Agency and Vancouver Prostate Centre). The industry partner is Amorfix Life Sciences Ltd and PREVENT - Pan Provincial Vaccine Initiative is the institutional partner....